Due to increasingly effective treatment options for metastatic breast cancer and the long disease progression in the metastatic stage, a growing number of patients are suffering from cerebral metastases, especially in the HER2-positive breast cancer subgroup (Müller et al., 2025). Here, ERBB2 is linked to breast carcinoma.